Nolok (Loteprednol Etabonate)

Loteprednol Etabonate, the active ingredient in Nolok, is a corticosteroid presented as an ophthalmic suspension for ocular use. It is employed to reduce inflammation in the eye following surgery, in allergic conjunctivitis, and in anterior uveitis.

GNH USA supplies Nolok as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across multiple regions. Clients benefit from reliable logistics and responsive technical support throughout the supply chain.

Loteprednol Etabonate is used in ophthalmology to control inflammatory processes affecting the anterior segment of the eye. - Post‑operative ocular inflammation: reduces swelling and pain after eye surgery, promoting faster healing. - Allergic conjunctivitis: alleviates redness, itching and swelling caused by allergic reactions. - Anterior uveitis: suppresses intra‑ocular inflammation to preserve vision and prevent complications.

Ocular administration of Loteprednol Etabonate may be associated with a range of local adverse reactions.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision. - Increased intraocular pressure. - Foreign body sensation. - Tearing. - Mild eye discomfort.

Serious or Rare Side Effects: - Allergic reaction (e.g., swelling, rash, difficulty breathing). - Corneal ulcer or erosion. - Severe elevation of intraocular pressure leading to glaucoma. - Cataract formation with prolonged use. - Fungal or bacterial eye infection. - Vision loss.

When prescribing Loteprednol Etabonate eye drops, clinicians should observe several precautionary measures to ensure safe use. - Monitor intraocular pressure: assess baseline and periodic IOP to detect steroid‑induced rise. - Avoid in active viral eye infections: use may exacerbate herpes simplex keratitis. - Caution in glaucoma patients: potential for pressure elevation. - Observe for signs of secondary infection: discontinue if bacterial or fungal infection develops. - Do not wear contact lenses during treatment: lenses can trap the medication and increase irritation. - Store at room temperature: keep in original container, protect from light and moisture.

Loteprednol Etabonate can interact with other ophthalmic or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid): - Concurrent systemic corticosteroids: additive immunosuppression may increase infection risk. - Use with potent CYP450 inhibitors (e.g., ketoconazole) when systemic absorption is possible: may raise systemic steroid levels. - Combination with anti‑glaucoma prostaglandin analogues: may counteract pressure‑lowering effect.

Moderate Interactions (Monitor Closely): - Co‑administration with non‑steroidal anti‑inflammatory eye drops: monitor for additive irritation. - Use with anticholinergic ophthalmic agents: may reduce drug penetration, adjust dosing if needed. - Concurrent use of antiviral eye drops: monitor for reduced antiviral efficacy.